Decline in adolescent treatment admissions for methamphetamine use in Cape Town by Pluddemann, Andreas et al.
RESEARCH
478  July 2013, Vol. 103, No. 7  SAMJ
Decline in adolescent treatment admissions for 
methamphetamine use in Cape Town
A Plüddemann,1 PhD; S Dada,1 MPH; C Parry,1,2 PhD
1 Alcohol and Drug Abuse Research Unit, South African Medical Research Council, Cape Town, South Africa
2 Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa
Corresponding author: A Plüddemann (apluddem@mrc.ac.za)
Background and objectives. The purpose of this report is to describe the changing trends in adolescent treatment admissions for 
methamphetamine in Cape Town, and to discuss possible implications.
Method. Data were collected on admissions for drug abuse treatment through a regular monitoring system involving drug treatment centres 
and programmes in Cape Town, every 6 months as part of the South African Community Epidemiology Network on Drug Use (SACENDU). 
A one-page form was completed by treatment centre personnel for each patient to collect demographic and substance abuse data.
Results. The results indicate that between 2004 and 2006, a significant increase in the proportion of adolescent treatment admissions for 
methamphetamine abuse occurred, while a significant decrease occurred between 2006 and 2011.
Conclusions. The initial increase in adolescent treatment admissions for methamphetamine abuse from 2004 to 2006, and subsequent 
decrease between 2006 and 2011, may suggest a change in methamphetamine abuse patterns among adolescents in Cape Town.
S Afr Med J 2013;103(7):478-480. DOI:10.7196/SAMJ.6529
The 2011 United Nations World Drug Report 
identified South Africa (SA) as one of the countries 
still experiencing ‘some increase’ in the use of 
‘undefined amphetamines’. Other countries and 
regions included were Australia and South-
East Asia.[1] In SA, the major contributor to an increase in 
the use of amphetamine-group substances has been an increase 
in consumption of methamphetamine in Cape Town and the 
surrounding Western Cape Province, documented via admissions 
to treatment centres and surveys among adolescents attending high 
schools.[2-5] These studies indicated an increase in admissions to 
specialist substance abuse treatment centres for methamphetamine 
abuse from <1% of patients in 2002, to 42% in the second half 
of 2006. High school surveys conducted between 2005 and 2008 
indicated a lifetime prevalence of methamphetamine use among 
learners of between 9% and 13%.[2-5]
The purpose of this report is to describe changes in adolescent 
treatment admissions for methamphetamine-related problems 
in Cape Town between 2004 and 2011, and to discuss the 
implications.
Methods
Study design
Established in 1996, the South African Community Epidemiology 
Network on Drug Use (SACENDU) is a network of researchers, 
practitioners and policymakers from 6 regions in SA who meet 
bi-annually to share community-level public health surveillance 
information about alcohol and other drug (AOD)-related trends. All 
AOD treatment centres are invited to volunteer to join the network. 
SACENDU collects data from more than 80% of treatment centres 
in Western Cape Province (most based in Cape Town) and includes 
state-funded, private non-profit, and private for-profit facilities in its 
network. Data therefore reflect the activities of treatment centres in 
the region. The focus of this paper is data obtained from between 23 
and 27 specialist substance abuse treatment centres between 2004 and 
2011. (The number of centres declined slightly over the 7 years, as a 
few small centres closed.)
Instruments
For the purpose of monitoring, a standardised 1-page form is 
completed for each person treated by a given centre during a 
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particular 6-month period. The form records responses concerning 
the source of referral for treatment, biographical information, the 
type of treatment received (in- and/or outpatient), the primary and 
secondary substances of abuse (including alcohol, over-the-counter 
and prescription medicines, and illicit drugs), the mode(s) of use, 
frequency of use, age at first use and whether the person had received 
treatment prior to the current episode. The form is based on the 
instrument developed by the Pompidou Group in Europe in the 
early 1990s and, more recently, on the Treatment Demand Indicators 
(TDI) used by the European Monitoring Centre for Drugs and Drug 
Addiction.[6] To ensure data quality, treatment centre personnel 
regularly receive training in data collection, and completed forms are 
checked for missing information and possible miscoding. Forms are 
completed by treatment centre personnel upon admission or shortly 
thereafter.
Ethics
Ethical approval for this study was provided by the South African 
Medical Research Council’s Ethics Committee and the University 
of Stellenbosch’s Health Research Ethics Committee. The study is a 
record review, and consent from patients was therefore not required.
Data analysis
Data were analysed using IBM SPSS version 20 and SAS. The 
Cochran-Armitage trend test was used to test for significant trends 
over time.
Results
Fig. 1 indicates that the proportion of adolescents (i.e. patients 
<20  years old) seeking treatment with methamphetamine as their 
primary substance of abuse increased steadily from 24.2% in the 
first half of 2004 (n=138/571) to 60.2% in the first half of 2006 
(n=436/724). This proportion, however, steadily began to decline 
from the second half of 2006 (58.6%: n=446/761) to the second 
half of 2011 (24.5%: n=105/429). The Cochran-Armitage Trend test 
showed this decrease to be significant (z=-20.06, p<0.0001). Notably, 
during the same time period, the proportion of adult patients (≥20 
years old) reporting methamphetamine as their primary substance 
of abuse increased significantly from 28.7% (n=551/1 927) in the 
first half of 2006 to 41.5% (n=949/2 288) in the second half of 2011 
(z=7.19, p<0.0001).
Between 2006 and 2011, the total number of adolescent and adult 
patients admitted to treatment centres during each 6-month period 
remained fairly constant, generally ranging between 2 600 and 2 900 
patients. Table 1 shows the proportions (as percentages) of different 
primary drugs reported by adolescent patients between 2006 and 
2011. The decline in methamphetamine as a primary substance 
of abuse was accompanied by a proportional increase in abuse of 
cannabis, and not other ‘hard drugs’. First-time admissions for 
adolescent patients remained between 80% and 93% of all admissions 
between 2006 and 2011, leaving fairly low numbers of previously 
treated patients.
Table 1. Primary substances of abuse for patients <20 years old – Western Cape (%)
Period Alcohol Cannabis Cannabis/mandrax Cocaine/crack Heroin Ecstasy Methamphetamine Other Total (N)
04a 5.1 33.1 23.3 3.7 8.2 0.9 24.9 1.1 571
04b 2.3 24.4 17.6 2.9 8.6 0.6 42.0 1.6 619
05a 2.5 24.5 9.3 1.9 11.5 0.8 48.7 0.9 637
05b 3.1 22.1 6.7 1.3 12.9 0.4 53.0 0.0 674
06a 1.7 17.4 3.9 0.6 15.3 0.0 60.2 1.0 724
06b 2.9 26.0 2.6 0.4 7.1 0.0 58.6 0.1 761
07a 3.6 24.4 2.4 0.6 9.6 0.1 56.5 0.0 803
07b 5.0 35.1 3.7 0.5 11.1 0.0 43.2 1.4 812
08a 5.0 33.1 3.5 0.6 10.1 0.2 45.5 0.0 622
08b 3.3 42.8 2.3 2.3 7.6 0.0 39.1 2.6 657
09a 5.0 39.6 3.3 0.3 6.3 0.0 42.4 0.0 902
09b 5.9 45.7 2.0 0.5 7.5 0.0 36.1 0.0 615
10a 6.9 45.4 5.4 0.3 6.6 0.1 33.3 0.0 702
10b 14.6 38.2 4.6 0.5 7.2 0.0 33.1 1.8 610
11a 6.5 60.5 2.6 0.3 3.5 0.0 25.3 1.3 620
11b 4.9 58.3 2.6 0.5 7.0 0.0 24.5 2.3 429
04a = January - June 2004, 04b = July - December 2004, etc.
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Fig. 1. Proportions of patients reporting methamphetamine as a primary 
substance of abuse by 6-monthly reporting period: patients aged ≤19 
(youth ) v. patients aged ≥20 (adults).
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Discussion
The data analysed in this survey indicate a significant decline 
in adolescent patients reporting methamphetamine as a primary 
substance of abuse between 2006 and 2011. Over the same period, 
a more gradual but significant increase in the proportion of adult 
patients reporting methamphetamine as a primary substance of 
abuse was observed. High school surveys conducted in Cape Town 
or Western Cape Province between 2005 and 2008 indicated self-
reported lifetime prevalence of methamphetamine use of between 
9% and 13%.[3-5] However, a random survey of 227 000 high school 
students in the Western Cape in 2011 found a lifetime prevalence 
of only 2%, with consistent proportions across the various ‘school 
districts’ within the province.[7]
Similar trends have been found in some other countries. A study 
in Canada found a decline in primary methamphetamine-related 
admissions to youth residential substance abuse treatment facilities. 
Comparing the years 2005 - 2006 and 2009 - 2010, the authors found 
that the estimated proportion of youth admissions to inpatient substance 
abuse treatment centres, primarily owing to methamphetamine, 
declined from 21% in 2005 - 2006 to 6% in 2009 - 2010.[8]
The decline was hypothesised as resulting from changes in 
government policy and legislation  concerning regulation of precursor 
chemicals and an accompanying increase in law enforcement. 
By comparison, proportions of adolescent patients admitted for 
treatment in the USA were relatively low between 2006 and 2010, 
with 3.8% of patients aged 12 - 17 years admitted for amphetamines 
(including methamphetamine) in 2006, but gradually declining to 
2.6% in 2010.[9] In Australia, treatment for amphetamines constituted 
only 7% of all treatment episodes in 2009/2010 and showed a slight 
decline between 2006 and 2010. In 2009/2010, <5% of treatment 
episodes for 10 - 19-year-olds were related to amphetamines.[10]
The fact that, in the present study, the decline in adolescent 
treatment admissions for methamphetamine was accompanied by an 
increase in the proportion of adolescent patients reporting cannabis 
as their primary drug, and not other ‘hard drugs’, is encouraging, as 
cannabis is considered less harmful than methamphetamine.
Over the period reported, efforts at addressing the abuse of 
methamphetamine included general information campaigns on the 
dangers of the drug, media coverage of methamphetamine-related 
crimes (that are often violent), and reports of increasing arrests for 
possession and dealing in methamphetamine. Interestingly, it appears 
that while this may have resulted in a downward trend of adolescent 
methamphetamine-related treatment admissions, the proportion 
of adult admissions continued to increase gradually. Foxcroft and 
Tsertsvadze[11] recently conducted three Cochrane systematic reviews 
on universal alcohol absuse prevention programmes for children and 
adolescents, and found that some universal interventions, particularly 
multi-component interventions, were effective in reducing alcohol 
consumption. Although alcohol and methamphetamine may not 
be entirely comparable, adolescents may be more susceptible to 
universal prevention messages aimed at adolescent substance use.
It remains a concern that the proportion of adult patients admitted 
for methamphetamine has continued to increase gradually since 
2006, suggesting a need for further intervention strategies that 
specifically target adults.
A limitation of this study was that it relied mainly on a single data 
source (although supported by high school surveys), and other data 
such as adolescent arrest data, presentations to trauma or psychiatric 
units at hospitals, or data from other health practitioners (e.g. general 
practitioners) could not be accessed as they are not routinely available 
in SA.
In conclusion, our findings indicate a significant decline in 
adolescent treatment admissions for methamphetamine abuse. This is 
an encouraging trend, and may suggest that preventive interventions 
are particularly effective among adolescents, who are a particularly 
vulnerable group. Further research is needed to establish the reasons 
behind the decline and which components of the prevention strategy 
have been most effective.
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